Structure-based generation of a new class of potent Cdk4 inhibitors:: New de novo design strategy and library design

被引:214
作者
Honma, T [1 ]
Hayashi, K [1 ]
Aoyama, T [1 ]
Hashimoto, N [1 ]
Machida, T [1 ]
Fukasawa, K [1 ]
Iwama, T [1 ]
Ikeura, C [1 ]
Ikuta, M [1 ]
Suzuki-Takahashi, I [1 ]
Iwasawa, Y [1 ]
Hayama, T [1 ]
Nishimura, S [1 ]
Morishima, H [1 ]
机构
[1] Merck Res Labs, Banyu Tsukuba Res Inst, Tsukuba, Ibaraki 3002311, Japan
关键词
D O I
10.1021/jm0103256
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
As a first step in structure-based design of highly selective and potent Cdk4 inhibitors, we performed structure-based generation of a novel series of Cdk4 inhibitors. A Cdk4 homology model was constructed according to X-ray analysis of an activated form of Cdk2. Using this model, we applied a new de novo design strategy which combined the de novo design program LEGEND with our in-house structure selection supporting system SEEDS to generate new scaffold candidates. In this way, four classes of scaffold candidates including diarylurea were identified. By constructing diarylurea informer libraries based on the structural requirements of Cdk inhibitors in the ATP binding pocket of the Cdk4 model, we were able to identify a potent Cdk4 inhibitor N-(9-oxo-9H-fluoren-4-yl)-N'-pyridin-2-ylurea 15 (IC50 = 0.10 muM), together with preliminary SAR. We performed a docking study between 15 and the Cdk4 model and selected a reasonable binding mode which is consistent with the SAR. Further modification based on the proposed binding mode provided a more potent compound, N-[(9bR)-5-oxo2,3,5,9b-tetrahydro-1H-pyrrolo[2,1-a]isoindol-9-yl]-N'-pyridin-2-ylurea 26a (IC50 = 0.042 muM), X-ray analysis of which was accomplished by the soaking method. The predicted binding mode of 15 in Cdk4 was validated by X-ray analysis of the Cdk2-26a complex.
引用
收藏
页码:4615 / 4627
页数:13
相关论文
共 57 条
[31]   A GEOMETRIC APPROACH TO MACROMOLECULE-LIGAND INTERACTIONS [J].
KUNTZ, ID ;
BLANEY, JM ;
OATLEY, SJ ;
LANGRIDGE, R ;
FERRIN, TE .
JOURNAL OF MOLECULAR BIOLOGY, 1982, 161 (02) :269-288
[32]   Protein kinase inhibition by staurosporine revealed in details of the molecular interaction with CDK2 [J].
Lawrie, AM ;
Noble, MEM ;
Tunnah, P ;
Brown, NR ;
Johnson, LN ;
Endicott, JA .
NATURE STRUCTURAL BIOLOGY, 1997, 4 (10) :796-801
[33]  
MANDUSKUIE TP, 1998, J MED CHEM, V41, P53
[34]   Inhibition of cyclin-dependent kinases, GSK-3β and CK1 by hymenialdisine, a marine sponge constituent [J].
Meijer, L ;
Thunnissen, AMWH ;
White, AW ;
Garnier, M ;
Nikolic, M ;
Tsai, LH ;
Walter, J ;
Cleverley, KE ;
Salinas, PC ;
Wu, YZ ;
Biernat, J ;
Mandelkow, EM ;
Kim, SH ;
Pettit, GR .
CHEMISTRY & BIOLOGY, 2000, 7 (01) :51-63
[35]  
*MOL SIM INC, 1998, QUANTA MOD ENV
[36]  
*MOL SIM INC, CAT DEV BIOC DISTR M
[37]  
MURCKO MA, 1997, PRACTICAL APPL COMPU, P304
[38]  
Murcko MA, 1997, PRACTICAL APPL COMPU, P322
[39]  
*NEC CO, BIOCESE
[40]   HIV-1 integrase pharmacophore: Discovery of inhibitors through three-dimensional database searching [J].
Nicklaus, MC ;
Neamati, N ;
Hong, HX ;
Mazumder, A ;
Sunder, S ;
Chen, J ;
Milne, GWA ;
Pommier, Y .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (06) :920-929